viTToria biotherapeutics

0 followers


Vittoria Biotherapeutics develops gene-edited cell therapies.  they provide next-generation, paradigm-shifting T-cell therapeutics that address unmet medical needs. Senza5 Technology from viTToria improves the efficacy, safety, and utility of cell-based treatments in preclinical settings.

Employees

11-50

Links


Org chart

Nicholas Siciliano
CEO, Co-Founder & Director
Collapse
Rosemary Mazanet
Chief Medical Officer
Adam Snook
Head, Preclinical Development
Aditya Nimmagadda
Senior Director, CMC
Steven Yang
Director, Laboratory Operations
Lori Forrest
Senior Controller
Keith Westby
Chief Operating Officer
Jay Mohr
Board Observer

Board & advisors

Bruce Peacock
Co-Founder & Chairman
Preston Noon
Director
Marco Ruella
Scientific Founder & SAB Chair
Carl June
Scientific Advisor
Michael Kalos
Scientific Advisor
Jian Irish
Scientific Advisor
Stephen Schuster
Scientific Advisor
Stefano Pileri
Scientific Advisor
Stefan Barta
Scientific Advisor


Offices

This company has no offices yet